Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sheridan

Showing results (341-350 of 7,541) with videos related to

Pageof 755
Sort By:
Nature Biotechnology|November 10, 2021
Sickle cell gene therapies approach watershedCormac Sheridan
Nature Biotechnology|December 16, 2021
Off-the-shelf, gene-edited CAR-T cells forge ahead, despite safety scareCormac Sheridan
Nature Biotechnology|October 7, 2022
Repairing the eyeCormac Sheridan
Nature Biotechnology|September 7, 2018
Roche splashes $2.4 billion on Foundation Medicine's cancer platformCormac Sheridan
JAMA|August 25, 2018
Blinded by SightSheridan Lam
Nephrology Nursing Journal : Journal of the American Nephrology Nurses' Association|October 26, 2012
The need for a comprehensive foot care modelStephanie Sheridan
The Veterinary Record|May 5, 1979
Unusual case of pyometraV Sheridan
Hospital Progress|October 1, 1979
Center pioneers program serving deaf patientsC Sheridan
Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies|February 4, 2015
Pediatric burn injury in Iraq and AfghanistanRob Sheridan
Nature Biotechnology|September 10, 2021
Oncologists greet Lumakras: the world's first KRAS inhibitorCormac Sheridan
Pageof 755

Showing results (341-350 of 7,541) with videos related to

Sort By:
Pageof 755
Nature Biotechnology|November 10, 2021
Sickle cell gene therapies approach watershedCormac Sheridan
Nature Biotechnology|December 16, 2021
Off-the-shelf, gene-edited CAR-T cells forge ahead, despite safety scareCormac Sheridan
Nature Biotechnology|October 7, 2022
Repairing the eyeCormac Sheridan
Nature Biotechnology|September 7, 2018
Roche splashes $2.4 billion on Foundation Medicine's cancer platformCormac Sheridan
JAMA|August 25, 2018
Blinded by SightSheridan Lam
Nephrology Nursing Journal : Journal of the American Nephrology Nurses' Association|October 26, 2012
The need for a comprehensive foot care modelStephanie Sheridan
The Veterinary Record|May 5, 1979
Unusual case of pyometraV Sheridan
Hospital Progress|October 1, 1979
Center pioneers program serving deaf patientsC Sheridan
Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies|February 4, 2015
Pediatric burn injury in Iraq and AfghanistanRob Sheridan
Nature Biotechnology|September 10, 2021
Oncologists greet Lumakras: the world's first KRAS inhibitorCormac Sheridan
Pageof 755